Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity
10.1038/sj.onc.1208549
Crossref journal-article
Springer Science and Business Media LLC
Oncogene (297)
Authors 2
  1. Séverine Seemann (first)
  2. Pierre Hainaut (additional)
References 43 Referenced 101
  1. Achanta G and Huang P . (2004). Cancer Res., 64, 6233–6239. (10.1158/0008-5472.CAN-04-0494)
  2. Arner ES and Holmgren A . (2000). Eur. J. Biochem., 267, 6102–6109. (10.1046/j.1432-1327.2000.01701.x)
  3. Bersani NA, Merwin JR, Lopez NI, Pearson GD and Merrill GF . (2002). Methods Enzymol., 347, 317–326. (10.1016/S0076-6879(02)47031-0)
  4. Bradford MM . (1976). Anal. Biochem., 72, 248–254. (10.1016/0003-2697(76)90527-3)
  5. Cho Y, Gorina S, Jeffrey PD and Pavletich NP . (1994). Science, 265, 346–355. (10.1126/science.8023157)
  6. Evans AR, Limp-Foster M and Kelley MR . (2000). Mutat. Res., 461, 83–108. (10.1016/S0921-8777(00)00046-X)
  7. Fabbro M and Henderson BR . (2003). Exp. Cell Res., 282, 59–69. (10.1016/S0014-4827(02)00019-8)
  8. Fei P and El Deiry WS . (2003). Oncogene, 22, 5774–5783. (10.1038/sj.onc.1206677)
  9. Freemerman AJ, Gallegos A and Powis G . (1999). Cancer Res., 59, 4090–4094.
  10. Fritz G, Grosch S, Tomicic M and Kaina B . (2003). Toxicology, 193, 67–78. (10.1016/S0300-483X(03)00290-7)
  11. Gaiddon C, Moorthy NC and Prives C . (1999). EMBO J., 18, 5609–5621. (10.1093/emboj/18.20.5609)
  12. Hainaut P and Hollstein M . (2000). Adv. Cancer Res., 77, 81–137. (10.1016/S0065-230X(08)60785-X)
  13. Hainaut P and Mann K . (2001). Antioxid. Redox Signal., 3, 611–623. (10.1089/15230860152542961)
  14. Hainaut P and Milner J . (1993a). Cancer Res., 53, 4469–4473.
  15. Hainaut P and Milner J . (1993b). Cancer Res., 53, 1739–1742.
  16. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K and Yodoi J . (1997). Proc. Natl. Acad. Sci. USA, 94, 3633–3638. (10.1073/pnas.94.8.3633)
  17. Hirota K, Murata M, Itoh T, Yodoi J and Fukuda K . (2001). FEBS Lett., 489, 134–138. (10.1016/S0014-5793(01)02094-4)
  18. Hirota K, Murata M, Sachi Y, Nakamura H, Takeuchi J, Mori K and Yodoi J . (1999). J. Biol. Chem., 274, 27891–27897. (10.1074/jbc.274.39.27891)
  19. Hofseth LJ, Hussain SP and Harris CC . (2004). Trends Pharmacol. Sci., 25, 177–181. (10.1016/j.tips.2004.02.009)
  20. Jayaraman L, Murthy KG, Zhu C, Curran T, Xanthoudakis S and Prives C . (1997). Genes Dev., 11, 558–570. (10.1101/gad.11.5.558)
  21. Kelley MR, Kow YW and Wilson III DM . (2003). Cancer Res., 63, 549–554.
  22. Lindahl T and Nyberg B . (1972). Biochemistry, 11, 3610–3618. (10.1021/bi00769a018)
  23. Makino Y, Yoshikawa N, Okamoto K, Hirota K, Yodoi J, Makino I and Tanaka H . (1999). J. Biol. Chem., 274, 3182–3188. (10.1074/jbc.274.5.3182)
  24. Matthews JR, Wakasugi N, Virelizier JL, Yodoi J and Hay RT . (1992). Nucleic Acids Res., 20, 3821–3830. (10.1093/nar/20.15.3821)
  25. Meplan C, Richard MJ and Hainaut P . (2000). Oncogene, 19, 5227–5236. (10.1038/sj.onc.1203907)
  26. Merrill GF, Dowell P and Pearson GD . (1999). Cancer Res., 59, 3175–3179.
  27. Merwin JR, Mustacich DJ, Muller EG, Pearson GD and Merrill GF . (2002). Carcinogenesis, 23, 1609–1615. (10.1093/carcin/23.10.1609)
  28. Offer H, Zurer I, Banfalvi G, Reha'k M, Falcovitz A, Milyavsky M, Goldfinger N and Rotter V . (2001). Cancer Res., 61, 88–96.
  29. Pavletich NP, Chambers KA and Pabo CO . (1993). Genes Dev., 7, 2556–2564. (10.1101/gad.7.12b.2556)
  30. Pearson GD and Merrill GF . (1998). J. Biol. Chem., 273, 5431–5434. (10.1074/jbc.273.10.5431)
  31. Pluquet O and Hainaut P . (2001). Cancer Lett., 174, 1–15. (10.1016/S0304-3835(01)00698-X)
  32. Rainwater R, Parks D, Anderson ME, Tegtmeyer P and Mann K . (1995). Mol. Cell. Biol., 15, 3892–3903. (10.1128/MCB.15.7.3892)
  33. Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Arai K, Yokota T and Wakasugi H . (1989). EMBO J., 8, 757–764. (10.1002/j.1460-2075.1989.tb03436.x)
  34. Takahashi K and Suzuki K . (1993). Int. J. Cancer, 55, 453–458. (10.1002/ijc.2910550322)
  35. Ueno M, Masutani H, Arai RJ, Yamauchi A, Hirota K, Sakai T, Inamoto T, Yamaoka Y, Yodoi J and Nikaido T . (1999). J. Biol. Chem., 274, 35809–35815. (10.1074/jbc.274.50.35809)
  36. Verhaegh GW, Richard MJ and Hainaut P . (1997). Mol. Cell. Biol., 17, 5699–5706. (10.1128/MCB.17.10.5699)
  37. Vousden KH and Lu X . (2002). Nat. Rev. Cancer, 2, 594–604. (10.1038/nrc864)
  38. Wei SJ, Botero A, Hirota K, Bradbury CM, Markovina S, Laszlo A, Spitz DR, Goswami PC, Yodoi J and Gius D . (2000). Cancer Res., 60, 6688–6695.
  39. Xanthoudakis S and Curran T . (1992). EMBO J., 11, 653–665. (10.1002/j.1460-2075.1992.tb05097.x)
  40. Xanthoudakis S, Miao G, Wang F, Pan YC and Curran T . (1992). EMBO J., 11, 3323–3335. (10.1002/j.1460-2075.1992.tb05411.x)
  41. Xanthoudakis S, Miao GG and Curran T . (1994). Proc. Natl. Acad. Sci. USA, 91, 23–27. (10.1073/pnas.91.1.23)
  42. Zhou J, Ahn J, Wilson SH and Prives C . (2001). EMBO J., 20, 914–923. (10.1093/emboj/20.4.914)
  43. Zurer I, Hofseth LJ, Cohen Y, Xu-Welliver M, Hussain SP, Harris CC and Rotter V . (2004). Carcinogenesis, 25, 11–19.
Dates
Type When
Created 20 years, 3 months ago (May 6, 2005, 4:30 p.m.)
Deposited 3 years, 5 months ago (March 22, 2022, 2:31 a.m.)
Indexed 1 month, 2 weeks ago (July 12, 2025, 6:53 p.m.)
Issued 20 years, 4 months ago (April 11, 2005)
Published 20 years, 4 months ago (April 11, 2005)
Published Online 20 years, 4 months ago (April 11, 2005)
Published Print 20 years, 2 months ago (June 2, 2005)
Funders 0

None

@article{Seemann_2005, title={Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity}, volume={24}, ISSN={1476-5594}, url={http://dx.doi.org/10.1038/sj.onc.1208549}, DOI={10.1038/sj.onc.1208549}, number={24}, journal={Oncogene}, publisher={Springer Science and Business Media LLC}, author={Seemann, Séverine and Hainaut, Pierre}, year={2005}, month=apr, pages={3853–3863} }